Genetic diversity and natural selection at the domain I of apical membrane antigen-1 (AMA-1) of Plasmodium falciparum in isolates from Iran

Experimental Parasitology

Volumn 130, Issue 4, 2012, Pages 456-462

  Mardani, Ahmad ^a   Keshavarz, Hossein ^a   Heidari, Aliehsan ^b   Hajjaran, Homa ^a   Raeisi, Ahmad ^a   Khorramizadeh, Mohammad Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ALBORZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Apical membrane antigen 1 (AMA 1); Genetic diversity; Iran; Malaria; Natural selection; Plasmodium falciparum

Indexed keywords

APICAL MEMBRANE ANTIGEN 1;

AMA 1 GENE; AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; ENDEMIC DISEASE; GENE AMPLIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENETIC DISTANCE; GENETIC POLYMORPHISM; GENETIC RECOMBINATION; GENETIC VARIABILITY; HAPLOTYPE; INTRAGENIC GENETIC RECOMBINATION; IRAN; MALARIA FALCIPARUM; NATURAL SELECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE ISOLATION; PHYLOGENETIC TREE; PLASMODIUM FALCIPARUM; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DOMAIN; SEQUENCE ANALYSIS;

AMINO ACID SEQUENCE; ANTIGENS, PROTOZOAN; BASE SEQUENCE; GENETIC VARIATION; HAPLOTYPES; HUMANS; IRAN; MALARIA VACCINES; MALARIA, FALCIPARUM; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; PHYLOGENY; PLASMODIUM FALCIPARUM; POLYMORPHISM, GENETIC; PROTOZOAN PROTEINS; SELECTION, GENETIC;

PLASMODIUM FALCIPARUM;

EID: 84859106308     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2012.01.006     Document Type: Article

References (43)

1. Babiker H.A., Ranford-Cartwright L.C., Currie D., Charlwood J.D., Billingsley P., Teuscher T., Walliker D. Random mating in a natural population of the malaria parasite Plasmodium falciparum. Parasitology 1994, 109:413-421.
2. Cortes A., Mellombo M., Mueller I., Benet A., Reeder J.C., Anders R.F. Geographical structure of diversity and differences between symptomatic and asymptomatic infections for Plasmodium falciparum vaccine candidate AMA1. Infect. Immun. 2003, 71:1416-1426.
3. Dutta S., Haynes J.D., Moch J.K., Barbosa A., Lanar D.E. Invasion-inhibitory antibodies inhibit proteolytic processing of apical membrane antigen 1 of Plasmodium falciparum merozoites. Proc. Natl. Acad. Sci. U S A 2003, 100:12295-12300.
4. Eisen D.P., Marshall V.M., Billman-Jacobe H., Coppel R.L. A Plasmodium falciparum apical membrane antigen-1 (AMA-1) gene apparently generated by intragenic recombination. Mol. Biochem. Parasitol. 1999, 100:243-246.
5. Escalante A.A., Cornejo O.E., Rojas A., Udhayakumar V., Lal A.A. Assessing the effect of natural selection in malaria parasites. Trends Parasitol. 2004, 20:388-395.
6. Escalante A.A., Grebert H.M., Chaiyaroj S.C., Magris M., Biswas S., Nahlen B.L., Lal A.A. Polymorphism in the gene encoding the apical membrane antigen-1 (AMA-1) of Plasmodium falciparum. X. Asembo Bay Cohort Project. Mol. Biochem. Parasitol. 2001, 113:279-287.
7. Escalante A.A., Lal A.A., Ayala F.J. Genetic polymorphism and natural selection in the malaria parasite Plasmodium falciparum. Genetics 1998, 149:189-202.
8. Fu Y.X., Li W.H. Statistical tests of neutrality of mutations. Genetics 1993, 133:693-709.
9. Garg S., Alam M.T., Das M.K., Dev V., Kumar A., Dash A.P., Sharma Y.D. Sequence diversity and natural selection at domain I of the apical membrane antigen 1 among Indian Plasmodium falciparum populations. Malaria Journal 2007, 6:154.
10. Genton B., Betuela I., Fekger I., Al-Yaman F., Anders R.F., Saul A., Rare L., Baisor M., Lorry K., Brown G.V., Pye D., Irving D.O., Smith T.A., Beck H.P., Alpers M.P. A recombination blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. J. Infect. Dis. 2002, 185:820-827.
11. Genton B., Reed Z.H. Asexual blood-stage malaria vaccine development: facing the challenges. Curr. Opin. Infect. Dis. 2007, 20:467-475.
12. Hodder A.N., Crewther P.E., Anders R.F. Specificity of the protective antibody response to apical membrane antigen 1. Infect. Immun. 2001, 69:3286-3294.
13. Hodder A.N., Crewther P.E., Matthew M.L.S.M., Reid G.E., Moritz R.L., Simpson R.J., Anders R.F. The disulfide bond structure of Plasmodium apical membrane antigen -1. J. Biol. Chem. 1996, 271:29446-29452.
14. Hughes M.K., Hughes A.L. Natural-selection on Plasmodium surface-proteins. Mol. Biochem. Parasitol. 1995, 71:99-113.
15. Jukes T.H., Cantor R.C. Evolution of protein molecules. Mammalian protein metabolism 1969, 21-132. Academic Press, New York. H.N. Munro (Ed.).
16. Kennedy M.C., Wang J., Zhang Y., Miles A.P., Chitsaz F., Saul A., Long C.A., Miller L.H., Stowers A.W. In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic response. Infect. Immun. 2002, 70:6948-6960.
17. Kocken C.H., Narum D.L., Massougbodji A., Ayivi B., Dubbeld M.A., van der Wel A., Conway D.J., Sanni A., Thomas A.W. Molecular characterization of Plasmodium reichenowi apical membrane antigen-1 (AMA-1), comparison with P. falciparum AMA-1, and antibody-mediated inhibition of red cell invasion. Mol. Biochem. Parasitol. 2000, 109:147-156.
18. Kocken C.H., Withers-Martinez C., Dubbeld M.A., van der Wel A., Hackett F., Valderrama A., Blackman M.J., Thomas A.W. High-level expression of the malaria blood-stage vaccine candidate Plasmodium falciparum apical membrane antigen 1 and induction of antibodies that inhibit erythrocyte invasion. Infect. Immun. 2002, 70:4471-4476.
19. Librado P., Rozas J. DnaSP v5: a software for comprehensive analysis of DNA polymorphism data. Bioinformatics 2009, 25:1451-1452.
20. Marshall V.M., Zhang L., Anders R.F., Coppel R.L. Diversity of the vaccine candidate AMA-1 of Plasmodium falciparum. Mol. Biochem. Parasitol. 1996, 77:109-113.
21. McDonald J.H., Kreitman M. Adaptive protein evolution at the Adh locus in Drosophila. Nature 1991, 351:652-654.
22. Mu J., Awadalla P., Duan J., McGee K.M., Joy D.A., McVean G.A., Su X.Z. Recombination hotspots and population structure in Plasmodium falciparum. PLoS Biol. 2005, 3:e335.
23. Nei M., Gojobori T. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol. Biol. Evol. 1986, 3:418-426.
24. Oliveira D.A., Udhayakumar V., Bloland P., Shi Y.P., Nahlen B.L., Oloo A.J., Hawley W.E., Lal A.A. Genetic conservation of the Plasmodium falciparum apical membrane antigen-1 (AMA-1). Mol. Biochem. Parasitol. 1996, 76:333-336.
25. Ord R.L., Tami A., Sutherland C.J. Ama1 genes of sympatric Plasmodium vivax and P. falciparum from Venezuela differ significantly in genetic diversity and recombination frequency. PLoS ONE 2008, 3:e3366.
26. Paul R.E., Packer M.J., Walmsley M., Lagog M., Ranford-Cartwright L.C., Paru R., Day K.P. Mating patterns in malaria parasite populations of Papua New Guinea. Science 1995, 269:1709-1711.
27. Peterson M.G., Marshall V.M., Smythe J.A., Crewther P.E., Lew A., Silva A., Anders R.F., Kemp D.J. Integral membrane protein located in the apical complex of Plasmodium falciparum. Mol. Cell Biol. 1989, 9:3151-3154.
28. Polhemus M.E., Magill A.J., Cummings J.F., Kester K.E., Ockenhouse C.F., Lanar D.E., Dutta S., Barbosa A., Soisson L., Diggs C.L., Robinson S.A., Haynes J.D., Stewart V.A., Ware L.A., Brando C., Krzych U., Bowden R.A., Cohen J.D., Dubois M.C., Ofori-Anyinam O., De-Kock E., Ballou W.R., Heppner D.G. Phase I dose escalation safety and immunogenicity trail of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naive adults at the Walter Reed Army Institute of Research. Vaccine 2007, 25:4203-4212.
29. Polley S.D., Chokejindachai W., Conway D.J. Allele frequency-based analyses robustly map sequence site under balancing selection in a malaria vaccine candidate antigen. Genetics 2003, 165:555-561.
30. Polley S.D., Conway D.J. Strong diversifying selection on domains of the Plasmodium falciparum apical membrane antigen 1 gene. Genetics 2001, 158:1505-1512.
31. Polley S.D., Mwangi T., Kocken C.H., Thomas A.W., Dutta S., Lanar D.E., Remarque E., Ross A., Williams T.N., Mwambingu G., Lowe B., Conway D.J., Marsh K. Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria. Vaccine 2004, 23:718-728.
32. Quang N.D., Hoa P.T., Tuan M.S., Viet N.X., Jalloh A., Matsuoka H. Polymorphism at the apical membrane antigen 1 gene (AMA1) of the malaria parasite Plasmodium falciparum in a Vietnamese population. Biochem. Genet. 2009, 47:370-383.
33. Rajesh V., Singamsetti V.K., Vidya S., Gowrishankar M., Elamaran M., Tripathi J., Radhika N.B., Kochar D., Ranjan A., Roy S.K., Das A. Plasmodium falciparum: genetic polymorphism in apical membrane antigen-1 gene from Indian isolates. Exp. Parasitol. 2008, 119:144-151.
34. Rand D.M., Kann L.M. Excess amino acid polymorphism in mitochondrial DNA: contrasts among genes form Drosoophila, mice, and humans. Mol. Biol. Evol. 1996, 13:735-748.
35. Sadrizadeh B. Malaria in the world, in the Eastern Mediterranean Region and in Iran: review article. WHO/EMRO Report 2001, 2001:1-13.
36. Sagara I., Dicko A., Ellis R.D., Fay M.P., Diawara S.I., Assadou M.H., Sissoko M.S., Kone M., Diallo A.I., Saye R., Guindo M.A., Kante O., Niambele M.B., Miura K., Mullen G.E., Pierce M., Martin L.B., Dolo A., Diallo D.A., Doumbo O.K., Miller L.H., Saul A. A randomized controlled phase 2 trial of the blood stage AMA1-C1/alhydrogel malaria vaccine in children in Mali. Vaccine 2009, 27:3090-3098.
37. Saul A., Lawrence G., Allworth A., Elliott S., Anderson K., Rzepczyk C., Martin L.B., Taylor D., Eisen D.P., Irving D.O., Pye D., Crewther P.E., Hodder A.N., Murphy V.J., Anders R.F. A human phase 1 vaccine clinical trial of the Plasmodium falciparum malaria vaccine candidate apical membrane antigen 1 in Montanide ISA720 adjuvant. Vaccine 2005, 23:3076-3083.
38. Snow R.W., Guerra C.A., Noor A.M., Myint H.Y., Hay S.I. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005, 434:214-217.
39. Tajima F. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 1989, 123:585-595.
40. Takala S.L., Coulibaly D., Thera M.A., Dicko A., Smith D.L., Guindo A.B., Kone A.K., Traore K., Ouattara A., Djimde A.A., Sehdev P.S., Lyke K.E., Diallo D.A., Doumbo O.K., Plowe C.V. Dynamics of polymorphism in a malaria vaccine antigen at a vaccine-testing site in Mali. PLoS Med. 2007, 4:e93.
41. Tamura K., Dudley J., Nei M., Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol. Biol. Evol. 2007, 24:1596-1599.
42. Thomas A.W., Waters A.P., Carr D. Analysis of variation in PF83, an erythrocytic merozoite vaccine candidate antigen of Plasmodium falciparum. Mol. Biochem. Parasitol. 1990, 42:285-287.
43. Verra F., Hughes A.L. Evidence for ancient balanced polymorphism at the Apical Membrane Antigen-1 (AMA-1) locus of Plasmodium falciparum. Mol. Biochem. Parasitol. 2000, 105:149-153.